Replimune Group, Inc. (REPL) Misses Q4 EPS by 234c

Replimune Group, Inc. (NASDAQ: REPL) reported Q4 EPS of ($2.99), $2.34 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c